Abbott price target raised to $162 from $159 at Barclays

Barclays raised the firm’s price target on Abbott (ABT) to $162 from $159 and keeps an Overweight rating on the shares. The firm recommends using the pullback following the in-line Q3 report as a buying opportunity. The shares were discounting a slightly stronger beat for Q3, the analyst tells investors in a research note. Barclays views the business weakness as temporary, and expects Abbott’s portfolio to return to growth toward the high end of its historical ranges in 2026 and beyond.